Related Experiment Video
Updated: Jan 24, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
When viral infections meet the anti-MDA5 antibody-positive dermatomyositis
Shuzi Liu1, Zheng Zhao2, Yabin Li1
1Department of Respiratory and Critical Care Medicine, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Abstract:
Anti-melanoma differentiation-related gene 5 (MDA5) antibody-positive dermatomyositis (anti-MDA5+ DM) is recognized as a distinct subtype of dermatomyositis, characterized by its frequent association with interstitial lung disease (ILD), particularly rapidly progressive ILD (RP-ILD), which is associated with a poor prognosis and high mortality. MDA5 functions as a cytoplasmic sensor for viral double-stranded RNA. The expression level of anti-MDA5 antibodies is positively correlated with disease severity. Notably, anti-MDA5 antibodies have been detected in patients infected with SARS-CoV-2. While the mechanisms underlying the generation of anti-MDA5 antibodies and their pathogenic role remain incompletely understood, accumulating data support the hypothesis that viral infections may trigger the production of these antibodies. This review provides a comprehensive analysis of the interplay between anti-MDA5 antibodies and viral infections in patients with anti-MDA5+ dermatomyositis (DM), with a focus on the potential mechanisms by which viral infections induce autoantibody formation.
Insights
Viral infections may trigger anti-melanoma differentiation-associated gene 5 (MDA5) antibody production in dermatomyositis (DM). This review explores the link between viral triggers and anti-MDA5 antibodies in DM, impacting interstitial lung disease prognosis.
Area of Science:
- Immunology
- Rheumatology
- Virology
Background:
- Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (anti-MDA5+ DM) is a distinct subtype associated with interstitial lung disease (ILD).
- Rapidly progressive ILD (RP-ILD) in anti-MDA5+ DM carries a poor prognosis and high mortality.
- MDA5 acts as a cytoplasmic sensor for viral double-stranded RNA, and its antibody levels correlate with disease severity.
Purpose of the Study:
- To comprehensively analyze the interplay between anti-MDA5 antibodies and viral infections in anti-MDA5+ DM.
- To focus on potential mechanisms by which viral infections induce autoantibody formation.
Main Methods:
- Literature review of studies investigating anti-MDA5 antibodies, dermatomyositis, and viral infections.
- Analysis of existing data on MDA5 function and its role in autoimmune responses.
- Synthesis of evidence linking viral infections to autoantibody production in DM.
Main Results:
- Accumulating data suggest viral infections may trigger the production of anti-MDA5 antibodies.
- Anti-MDA5 antibodies have been detected in patients with SARS-CoV-2 infection.
- The precise mechanisms of anti-MDA5 antibody generation and their pathogenic role require further elucidation.
Conclusions:
- Viral infections are hypothesized to be a significant trigger for anti-MDA5 antibody formation in dermatomyositis.
- Understanding this interplay is crucial for managing anti-MDA5+ DM and associated ILD.
- Further research is needed to fully elucidate the pathogenic mechanisms and therapeutic implications.
Related Concept Videos
Viral Recombination
Viral Structure
Position-effect Variegation
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Position and Displacement
Serial Position Effect

